INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 81 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $691,000 | +92.5% | 213,942 | -19.4% | 0.00% | – |
Q4 2016 | $359,000 | -8.2% | 265,558 | +5.9% | 0.00% | – |
Q3 2016 | $391,000 | +64.3% | 250,879 | +40.4% | 0.00% | – |
Q2 2016 | $238,000 | -71.0% | 178,736 | +14.7% | 0.00% | -100.0% |
Q1 2016 | $821,000 | -57.6% | 155,864 | -36.8% | 0.00% | 0.0% |
Q4 2015 | $1,935,000 | -36.2% | 246,514 | -31.4% | 0.00% | -50.0% |
Q3 2015 | $3,035,000 | -25.6% | 359,204 | -3.6% | 0.00% | -33.3% |
Q2 2015 | $4,079,000 | -17.3% | 372,536 | +5.6% | 0.00% | 0.0% |
Q1 2015 | $4,930,000 | +18.9% | 352,633 | +43.6% | 0.00% | 0.0% |
Q4 2014 | $4,147,000 | +72.3% | 245,557 | +36.9% | 0.00% | +50.0% |
Q3 2014 | $2,407,000 | +2.4% | 179,333 | -2.8% | 0.00% | 0.0% |
Q2 2014 | $2,351,000 | +6.6% | 184,565 | -0.5% | 0.00% | 0.0% |
Q1 2014 | $2,206,000 | -14.9% | 185,558 | -1.2% | 0.00% | 0.0% |
Q4 2013 | $2,593,000 | -22.5% | 187,798 | -2.0% | 0.00% | -33.3% |
Q3 2013 | $3,346,000 | +5.7% | 191,726 | -1.6% | 0.00% | 0.0% |
Q2 2013 | $3,167,000 | – | 194,863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
Bleichroeder LP | 250,000 | $530,000 | 0.10% |
PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |